Author:
Thies A,Dautel P,Meyer A,Pfüller U,Schumacher U
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Barbieri L, Battelli MG, Stirpe F (1993) Ribosome-inactivating proteins from plants. Biochem Biophys Acta 1154: 237–282
2. Beuth J (1997) Clinical relevance of immunoactive mistletoe lectin-I. Anticancer Drugs 8: 53–55
3. Bock PR, Friedel WE, Hanisch J, Karasmann M, Schneider B (2004) Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results from a multi-center, comparative, epidemiological cohort study in Germany and Switzerland. Arzneimittelforschung 54: 456–466
4. Büssing A, Suzart K, Bergmann J, Pfüller U, Schietzel M, Schweizer K (1996) Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins. Cancer Lett 99: 59–72
5. Büssing A, Suzart K, Schweizer K (1997) Differences in the apoptosis-inducing properties of Viscum album L. extracts. Anticancer Drugs 8: 9–14
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献